175201-96-4

Basic information

• Product Name: N'-HYDROXY-2-(2-THIENYLSULFONYL)ETHANIMIDAMIDE
• Synonyms: N'-HYDROXY-2-(2-THIENYLSULFONYL)ETHANIMIDAMIDE;N'-hydroxy-2-(2-thienylsulphonyl)ethanimidamide;(THIEN-2-YLSULFONYL)ACETAMIDE OXIME;N-Hydroxy-2-(thiophen-2-ylsulfonyl)acetiMidaMide
• CAS NO: 175201-96-4
• Molecular Formula: C6H8N2O3S2
• Molecular Weight: 220.27
• Mol File: 175201-96-4.mol

Chemical Properties

• Appearance: /
• Solubility: DCM, DMSO, Ethyl Acetate, Methanol
• CAS DataBase Reference: N'-HYDROXY-2-(2-THIENYLSULFONYL)ETHANIMIDAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: N'-HYDROXY-2-(2-THIENYLSULFONYL)ETHANIMIDAMIDE(175201-96-4)
• EPA Substance Registry System: N'-HYDROXY-2-(2-THIENYLSULFONYL)ETHANIMIDAMIDE(175201-96-4)

Safety Data

• Hazardous Substances Data: 175201-96-4(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
N'-HYDROXY-2-(2-THIENYLSULFONYL)ETHANIMIDAMIDE is used as an intermediate in the synthesis of class II human histone deacetylase inhibitors for their potential therapeutic applications in treating various diseases, including cancer and neurological disorders. The compound's unique structure allows for the development of novel inhibitors that can modulate the activity of histone deacetylases, thereby affecting gene expression and cellular processes.
Used in Cancer Treatment:
N'-HYDROXY-2-(2-THIENYLSULFONYL)ETHANIMIDAMIDE is used as a key component in the development of histone deacetylase inhibitors, which are employed as anticancer agents. These inhibitors can modulate the activity of histone deacetylases, leading to changes in gene expression that can inhibit tumor growth and progression. By targeting specific histone deacetylases, these inhibitors can potentially be used to treat various types of cancer, including solid tumors and hematological malignancies.
Used in Neurological Disorders:
In addition to its applications in cancer treatment, N'-HYDROXY-2-(2-THIENYLSULFONYL)ETHANIMIDAMIDE is also used in the development of histone deacetylase inhibitors for the treatment of neurological disorders. These inhibitors can modulate the epigenetic landscape of neurons, potentially leading to the amelioration of symptoms and disease progression in conditions such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis.
Used in Drug Delivery Systems:
N'-HYDROXY-2-(2-THIENYLSULFONYL)ETHANIMIDAMIDE can be utilized in the development of novel drug delivery systems to improve the bioavailability and therapeutic outcomes of histone deacetylase inhibitors. By employing various organic and metallic nanoparticles as carriers, the compound can be effectively delivered to target cells, enhancing its efficacy and minimizing potential side effects.